Authors: Griebel, G Perrault, G Simiand, J Cohen, C Granger, P Decobert, M Francon, D Avenet, P Depoortere, H Tan, S Oblin, A Schoemaker, H Evanno, Y Sevrin, M George, P Scatton, B

Citation: G. Griebel et al., SL651498: An anxioselective compound with functional selectivity for alpha(2)- and alpha(3)-containing gamma-aminobutyric acid(A) (GABA(A)) receptors, J PHARM EXP, 298(2), 2001, pp. 753-768

Authors: Davi, H Tronquet, C Miscoria, G Perrier, L Dupont, P Caix, J Simiand, J Berger, Y

Citation: H. Davi et al., Disposition of irbesartan, an angiotensin II AT1-receptor antagonist, in mice, rats, rabbits, and macaques, DRUG META D, 28(1), 2000, pp. 79-88

Authors: Davi, H Tronquet, C Caix, J Simiand, J Briot, C Berger, Y Thiercelin, JF

Citation: H. Davi et al., Disposition of tiludronate (Skelid (R)) in animals, XENOBIOTICA, 29(10), 1999, pp. 1017-1031

Authors: Bignon, E Alonso, R Arnone, M Boigegrain, R Brodin, R Gueudet, C Heaulme, M Keane, P Landi, M Molimard, JC Olliero, D Poncelet, M Seban, E Simiand, J Soubrie, P Pascal, M Maffrand, JP Le Fur, G

Citation: E. Bignon et al., SR146131: A new potent, orally active, and selective nonpeptide cholecystokinin subtype 1 receptor agonist. II: In vivo pharmacological characterization, J PHARM EXP, 289(2), 1999, pp. 752-761